Cargando…
COVID 19 and the Systematic Use of Aspirin in Diabetics During Hospitalization: A Retrospective Study
Background and Aims Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, has infected more than 153 million people and led to the death of 3.3 million others. It is estimated that people with cardiovascular risk factors are more prone for mortality and intub...
Autores principales: | Vlachopoylou, M., Hamissa, E.M., AbdAlgaffar, S.A., Chatzis, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Mosby, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556493/ http://dx.doi.org/10.1016/j.ahj.2021.10.017 |
Ejemplares similares
-
QTc Prolongation in SARS-CoV-2 (COVID-19) Patients Receiving Hydroxycloroquine: A Retrospective Study
por: Vlachopoylou, M., et al.
Publicado: (2021) -
COVID 19 at ischemic heart disease, A retrospective study
por: Vlachopoulou, M., et al.
Publicado: (2021) -
Demographics of COVID 19 admitted patients and obesity: a retrospective study
por: Vlachopoulou, M., et al.
Publicado: (2022) -
Use of aspirin for primary prevention in patients with diabetes during the COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2021) -
Retrospective analysis of aspirin's role in the severity of COVID-19 pneumonia
por: Gogtay, Maya, et al.
Publicado: (2022)